Trials / Conditions / Stage IVB Gallbladder Cancer
Stage IVB Gallbladder Cancer
5 registered clinical trials studyying Stage IVB Gallbladder Cancer.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder NCT02042443 | National Cancer Institute (NCI) | Phase 2 |
| Completed | ADH-1, Gemcitabine Hydrochloride & Cisplatin in Treating Metastatic Pancreatic or Biliary Tract Cancer NCT01825603 | University of Nebraska | Phase 1 |
| Withdrawn | Selumetinib and Akt Inhibitor MK-2206 in Treating Patients With Refractory or Advanced Gallbladder or Bile Duc NCT01859182 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointest NCT01643499 | University of Chicago | Phase 1 |
| Completed | Triapine and Gemcitabine Hydrochloride in Gallbladder Cancer NCT00075504 | National Cancer Institute (NCI) | Phase 2 |